ZMYND11 | Zinc finger, MYND-type containing 11 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
WDR37 | WD repeat domain 37 | | | | | | Expressed in all |
PITRM1 | Pitrilysin metallopeptidase 1 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
FBXO18 | F-box protein, helicase, 18 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RBM17 | RNA binding motif protein 17 | Plasma proteins
| | | | | Expressed in all |
PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
CELF2 | CUGBP, Elav-like family member 2 | | | | | | Expressed in all |
CDC123 | Cell division cycle 123 | | | | | | Expressed in all |
OPTN | Optineurin | Disease related genes
| | | | | Expressed in all |
PHYH | Phytanoyl-CoA 2-hydroxylase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
PRPF18 | Pre-mRNA processing factor 18 | | | | | | Expressed in all |
SUV39H2 | Suppressor of variegation 3-9 homolog 2 (Drosophila) | Enzymes
| | | | | Tissue enriched |
VIM | Vimentin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
STAM | Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | | | | | | Expressed in all |
MRC1L1 | CDNA FLJ56855, highly similar to Macrophage mannose receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
MRC1 | Mannose receptor, C type 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
NEBL | Nebulette | | | | | | Tissue enhanced |
BMI1 | BMI1 polycomb ring finger oncogene | Cancer-related genes
| | | | | Expressed in all |
ARMC3 | Armadillo repeat containing 3 | | | | | | Group enriched |
MSRB2 | Methionine sulfoxide reductase B2 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C10orf115 | Chromosome 10 open reading frame 115 | | | | | | Tissue enhanced |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
ENKUR | Enkurin, TRPC channel interacting protein | | | | | | Tissue enriched |
GAD2 | Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | Enzymes
| | | | | Tissue enriched |
APBB1IP | Amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Cytoskeleton related proteins
| | | | | Mixed |
ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted membrane proteins
| | | | | Expressed in all |
PTCHD3 | Patched domain containing 3 | Predicted membrane proteins
| | | | | Tissue enriched |
RAB18 | RAB18, member RAS oncogene family | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MPP7 | Membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) | | | | | | Expressed in all |
C10orf126 | Chromosome 10 open reading frame 126 | | | | | | Tissue enriched |
MTPAP | Mitochondrial poly(A) polymerase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
ZEB1 | Zinc finger E-box binding homeobox 1 | Disease related genes Transcription factors
| | | | | Expressed in all |
ARHGAP12 | Rho GTPase activating protein 12 | | | | | | Expressed in all |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
NRP1 | Neuropilin 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CREM | CAMP responsive element modulator | Transcription factors
| | | | | Expressed in all |
CCNY | Cyclin Y | | | | | | Expressed in all |
RASGEF1A | RasGEF domain family, member 1A | | | | | | Tissue enhanced |
HNRNPF | Heterogeneous nuclear ribonucleoprotein F | Plasma proteins
| | | | | Expressed in all |
TMEM72 | Transmembrane protein 72 | Predicted membrane proteins
| | | | | Tissue enriched |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
MARCH8 | Membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Expressed in all |